Brand / product

Mediroxine

Cefuroxime · 125 mg/5 mL

ShareSend this page
₨ Official source-observed price PKR 380.13 50ml
PKR 7.60 / mL
✓ Official DRAP price source observed · Source checked 2026-11-14
Price Intelligence

Equivalent price position

Same generic · strength · dosage form · compatible unitPrice Intelligence PRO →
This brandPKR 7.60/ mL
Price position17% above medianvs like-for-like peer median
Peer comparators3current-price listings
🔒
MedInfoBase Pharma Pro

Unlock the full competitive price benchmark

See the exact peer median, min/max and quartiles, product rank, price percentile and the complete like-for-like competitor table.

Rank & percentilePeer medianFull competitor listPortfolio intelligence
View Price Intelligence PRO

Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.

Product details

Generic
Cefuroxime
Therapeutic area
Anti-infectives
Drug class
Second-generation cephalosporins
ATC
J01DC
Strength
125 mg/5 mL
Dosage form
Dry suspension
Pack
50ml
Registration no.
044380
Price record verified
2026-08-09
Latest DRAP source check
2026-11-14 03:07

Manufacturer

Mediate Pharmaceutical Pvt Ltd

Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.

View company portfolio →

What Mediroxine (Cefuroxime) is used for

Cefuroxime is an antibiotic from the cephalosporin group. It treats infections caused by bacteria by stopping the bacteria from growing. It comes as tablets and a liquid to take by mouth (as cefuroxime axetil), and as a powder that a doctor or nurse makes into an injection or drip (as cefuroxime sodium), usually in hospital. It is a prescription medicine. WHO lists cefuroxime injection in its 'Watch' group of antibiotics.

  • Throat and tonsil infections caused by streptococcus bacteria
  • Sinus infections and middle ear infections
  • Flare-ups of chest infection in people with long-term lung disease (COPD), and sometimes pneumonia
  • Bladder infections (cystitis) and kidney infections
  • Skin and soft tissue infections
  • Early Lyme disease (an infection spread by tick bites)

Get medical help straight away if

  • Get emergency help for signs of a severe allergic reaction: an itchy raised rash, swelling of the face, lips, mouth or throat, wheezing or trouble breathing or swallowing, a fast heartbeat, dizziness or fainting.
  • Get emergency help for chest pain during an allergic reaction. This can be a sign of an allergic heart problem (Kounis syndrome).
  • Stop taking it and get medical help straight away for a serious skin reaction: target-shaped spots, blistering or peeling skin, sores in the mouth, or a widespread rash with fever and swollen glands.
  • Contact a doctor straight away for severe or watery diarrhoea, especially with blood or mucus, stomach cramps or fever. This can happen during treatment or some time after it ends.

Side effects, warnings and interactions for Cefuroxime

Prepared from the sources listed by the MedInfoBase team. General information, not medical advice: it gives no doses. Your doctor or pharmacist decides the medicine and dose for you.

Our condition guides that mention Cefuroxime

From our condition guides, written from WHO, NICE and other opened sources. Your doctor decides if Cefuroxime is right for you and the dose.

  • Pneumonia: used with a macrolide or doxycycline for adults with other illnesses, and given into a vein in hospital for more severe pneumonia
Summary

About Mediroxine 125 mg/5 mL dry suspension

Mediroxine 125 mg/5 mL dry suspension contains Cefuroxime 125 mg/5 mL. It is registered with DRAP by Mediate Pharmaceutical Pvt Ltd (registration no. 044380). Its official price is PKR 380.13 for a pack of 50ml. The price changed from PKR 362.23 to PKR 380.13 on 13 November 2026. Mediroxine is also available as 1.5 g injection, 125 mg tablet and 250 mg tablet. 3 other brands of Cefuroxime 125 mg/5 mL (dry suspension) are registered in Pakistan. Compare all brands and prices →

Same brand

Other strengths of Mediroxine

Alternatives (substitutes): same medicine, strength and form

All 3 other brands of Cefuroxime 125 mg/5 mL suspension in Pakistan

These 3 brands are alternatives (substitutes) to Mediroxine: each contains Cefuroxime 125 mg/5 mL suspension. Ask your doctor or pharmacist before you switch brands.

Sorted by price per mL, lowest first. The lowest is Retarox (Arreta Pharmaceuticals (Pvt.) Ltd) at PKR 5.10 per mL; the highest is CEFUROX at PKR 8.72. All prices are official DRAP prices.

BrandCompanyPackOfficial pricePer unit
RetaroxArreta Pharmaceuticals (Pvt.) Ltd60mlPKR 306.03PKR 5.10 / mL
CeftinEpharm Laboratories60mlPKR 388.35PKR 6.47 / mL
CEFUROXMEDICAIDS PAKISTAN PVT LTD50 mlPKR 435.84PKR 8.72 / mL

See every strength and form of Cefuroxime →

Where to buy

MedInfoBase does not sell medicines and takes no orders. The company below holds the DRAP registration for Mediroxine, so it is the right place for a pharmacy, distributor or hospital buyer to ask about supply. A patient should buy from a licensed pharmacy.

Registration holder
Mediate Pharmaceutical Pvt Ltd, Karachi
DRAP registration
044380
Phone
+92 21 35074746-7
Email
info@mediatepharma.com
Website
https://www.mediatepharma.com/
Contact page
Company contact page

Contact details as published by the company, last checked on 18 October 2026 (not yet independently verified). The price on this page is the official DRAP maximum retail price: a pharmacy may charge that or less, never more.

Price movement

Official price over time

PKR 362.23 to 380.13 (+4.9%) between 1 Jul 2025 and 13 Nov 2026 · 2 official price records · pack 50ml

Step chart: a notified price holds until DRAP notifies the next one. Hover or tap a point for its date and change.

Cite this price history

MedInfoBase. Mediroxine 125 mg/5 mL, 50ml: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/mediroxine-125-mg-5-ml-044380-50ml-mediate-pharmaceutical-pvt-ltd/ (accessed 14 November 2026).

Traceability

Official price history

AmountEffective fromVerifiedSourceStatus
PKR 380.132026-11-132026-11-14DRAP PharmaPrice Index (refreshed from snapshot #137)Current
PKR 362.232025-07-012026-08-09DRAP PharmaPrice IndexHistorical
Evidence note: “Source observed” means MedInfoBase captured the record from an official DRAP source; it does not by itself mean the product registration was independently matched in the DRAP registry. Price note: Unit-price comparisons are informational calculations from official-source pack prices and normalized pack quantities. A pharmacy's transaction price may differ. Verify current regulatory and product information before professional use.

Cite this record

Medicine record · DRAP registration 044380
MedInfoBase. (2026). Mediroxine 125 mg/5 mL Dry suspension (50ml), Mediate Pharmaceutical Pvt Ltd — registration and price record [Data set]. MedInfoBase. Retrieved November 14, 2026, from https://medinfobase.com/brand/mediroxine-125-mg-5-ml-044380-50ml-mediate-pharmaceutical-pvt-ltd/ Data observed 14 November 2026. Source: DRAP PharmaPrice Index (refreshed from snapshot #137). DRAP registration 044380.
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Price and registration data on this page were observed on 14 November 2026. Records change over time, so please cite the observation date alongside the access date.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9